Intismeran:First successful Phase 3 trial for Personalised Vaccines

A 200X photomicrograph magnification of a direct by Centers for Disease Control and Prevention is licensed under CC-CC0 1.0

Vaccines have been the most successful tool in public health for over 150 years. But up to now they have been generic: each one is raised and designed against a specific disease-such as rabies, smallpox and more recently malaria. A new class of vaccine changes that logic entirely. These are individualised neoantigen vaccines, built from the unique mutations in each patient’s tumour. Today we highlight the first positive Phase 3 results for one of these, as reported by the BBC’s Joe McFadden. [1]

Intismeran is constructed from the mutational “fingerprint” of each patient’s melanoma — a bespoke mRNA vaccine rather than a one‑size‑fits‑all jab. In the Phase 3 INTerpath‑001 trial, jointly run by Merck and Moderna, 1,137 patients with completely resected stage IIB–IV melanoma were randomised to receive either Keytruda (Merck’s anti‑PD‑1 therapy) alone or Keytruda plus Intismeran.[2] [3] This is how Joe summarises the early results:

Early results show this new jab extended the length of time these patients were cancer free, but it’s unclear for how long, according to an announcement by the two firms.

Encouraging, we say: hats off to the companies and scientists involved. As for the wider reaction from the scientific community, it is positive indeed, but we’ll leave it to Joe to tell you about that

At this point we invoke our two favourite LSS tropes: caution and caveat. This is an early-days report: the work must now jump all the usual hoops of peer review, regulatory approval scaling and much more before any kind of routine clinical applications are possible. But there are many reasons to be optimistic, not just about Intismeran, but also certain wider preoccupations of ours. Firstly: some of the best research is done by that happy, hard to define network of companies, research institutes and académe, which has done so much to transform the human condition since the nineteenth century. Secondly, genetic engineering, which we follow avidly here, is in its infancy-this is quite different to our regular antibiotics theme, isn’t it? But most of all, if you want life to really get better, stop believing in what you want to believe and start believing in the scientific method.

[1] Vaccine breakthrough stops cancer returning in trial – BBC News

[2] Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma

[3] Merck-Moderna cancer vax slows recurrence in ph. 3 trial

# Intismeran # Keytruda #melanoma #vaccine #mRNA #health #medicine #cancer #reseach #peer review

Round up Birth order, resistant fungus, solar missions and much more

a few examples from this week’s news

Is Birth order Destiny? We’ve long been intrigued by the thought that your birth order-whether you’re a sibling or an older child, older brother, younger sister,etc-affects your personality and life chances. Latest twist in the saga is this piece about disease from the Independent: Study suggests first-born children are more likely to develop neurological conditions and second-born are more prone to substance abuse

https://www.independent.co.uk/news/science/first-and-second-born-disease-risk-b3028407.html?fbclid=IwY2xjawTicCtwZG9mBWV4dG4DYWVtAjEwAGJyaWQRMFU1SjR6Q2hsamtwamFOMUxzcnRjBmFwcF9pZBAyMjIwMzk

Recalcitrant Fungus “A drug-resistant fungus that kills thousands of hospital patients in the U.S. every year survives on human skin by hijacking the body’s immune response, scientists have just discovered.” declares Newsweek. So it’s not just bacteria then?

https://www.newsweek.com/deadly-fungus-kills-thousands-every-year-scientists-found-where-it-hides-12297119?utm_medium=Social&utm_source=Facebook&fbclid=IwY

Is all this heat doing in your brain? A few years ago we published a blog speculating that extra carbon dioxide from global warming may be affecting our health (LSS 2 11 20) Well that may or may not be the case: but all that extra heat may well be affecting our brains, as this article from The Conversation makes clear indeed

https://theconversation.com/too-hot-to-think-why-extreme-heat-can-affect-how-well-our-brain-works-289170?utm_medium=email&utm_campaign=Latest%20

Yet more quantum complexity As if quantum physics wasn’t already difficult enough to follow, what with all those bosons, muons hadrons and quarks, Nature Briefing has just made our life a little more difficult with this piece about the Gluon How are we meant to remember all this?

A team of physicists says it has observed strong evidence of a mysterious ‘glueball’, a particle made up of force-carrying gluons. The team says that a particle known as X (2370) is mostly made up of these glueballs — clusters of the gluons that bind quarks to form protons and neutrons and hold them inside the nucleus of an atom. There is no single smoking gun that proves that this particle is made of glueballs, says particle physicist Bruce Yabsley. But the findings are “quite persuasive”, he says. The group presented their results at the International Conference on High Energy Physics in Natal, Brazil, last week.

Nature | 5 min read

Why won’t ET phone us? Normally our Friday purpose is to bring you short snappy pieces before Cocktail Hour. But this Guardian Long Read on why those pesky aliens have never shown up is so very good that we felt it our duty to bring it to you nevertheless

https://www.theguardian.com/news/2026/aug/11/the-great-silence-why-havent-we-found-any-aliens-yet

India’s day in the Sun If there’s one nation that is making huge leaps-commercial, technological, scientific- it is India. Proof if you want more comes from this admirable solar mission Aditya L1, admirably reported by the BBC

Aditya-L1: Indian solar mission’s new findings throw light on enduring Sun mysteries – BBC News

Quote of the week

Behold, how good and how pleasant it is for brethren to dwell together in unity!” — Psalm 133:1

#india #space #solar #global warming #antibiotic resistance #birth order #physics #climate #psychology #family #health #medicine

More good news on designer phages-and why we think they’ll work

Last week, with the help of our doughty researchers, we published a small piece describing how Artificial Intelligence is being employed to design new generations of bacteriophages, some of which might be used to target antibiotic‑resistant bacteria (LSS 8.8.26). Hopeful, certainly — but intelligent readers will ask the old question: what’s the chance any of this will work anytime soon?

Well, you’ll be glad to know that human‑modified bacteriophages have already been in action, and successfully too, since the far‑off days of 2024. They weren’t using AI to design the phages then, merely modifying them using another LSS favourite: CRISPR‑Cas9 gene editing.

Our first trope concerns a report in The Lancet Microbe, a long but reasonably readable paper describing a safety and tolerability trial of SNIPR001 — a combination of four CRISPR–Cas‑equipped bacteriophages — in healthy human volunteers. Results were encouraging:

“SNIPR001 was safe and well tolerated in healthy participants, with signals suggesting targeted activity against E. coli, despite the absence of a statistically significant effect.”

Our second trope comes from the excellent Michael Le Page of New Scientist, who reports on the clinical use of the same SNIPR technology — not a trial in healthy volunteers, but in an actual patient. His piece, CRISPR‑armed phages help treat severe superbug infection, is unfortunately behind a paywall, but worth crossing. It tells the story of a 65‑year‑old man in California with a severe, antibiotic‑resistant E. coli infection whose condition markedly improved after receiving these engineered phages. The lesson is clear: artificially-modified phages can work.

Now, nobody is claiming miracle cures — not the authors of the paper, nor Michael, nor ourselves. But all of us, in our different ways, are pointing to extremely encouraging signs. And remember our original point: all of the above took place, before our famous AI‑designed bacteriophages have even gone into trial. What possibilities might open up when they are fully deployed?

[1] Safety, recovery, and pharmacodynamics of CRISPR–Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation study – The Lancet Microbe

[2] CRISPR-armed phages help treat severe superbug infection | New Scientist

# Artificial Intelligence # bacteriophages # SNIPR001 # CRISPR‑Cas9 #antibiotic resistance #bacteria #microbiology #medicine #health

Will Quantum sensing be bigger than Quantum Computing?

At LSS we’re a pretty eclectic kind of blog. So when we think we’ve got into a rut -too much on Antibiotics, Anthropoid Ape Men, or the deeds of Mr Trump- we like to spin the wheel so that you, gentle readers, may be the first to become au fait in yet another exciting area of cutting-edge human endeavour. And today we have chosen Quantum Sensing, that quiet shy sister of the much louder Quantum Computing, which might just turn out to be the Cinderella who scooped the ball. [1]

So what is Quantum sensing? The scientific miracle that crept up on us while everyone was busy arguing about quantum computing. Instead of trying to build impossible machines, quantum sensing takes the strange behaviour of atoms, photons and spins and uses it to measure the world with a delicacy classical physics simply can’t reach.

What’s the step change? A quantum sensor doesn’t rely on bulk electronics or brute force; it relies on superposition, entanglement and other quantum states that are inherently more precise. The result is a new class of instruments that can detect the faintest magnetic fields, the tiniest vibrations, and the most subtle changes in gravity — a kind of scientific eyesight that feels almost unfair in its sharpness.

What makes quantum sensing genuinely new? Classical sensors, like rulers, are always fighting noise: thermal noise, electronic noise, environmental noise. Quantum sensors sidestep those constraints by using states of matter that are the limit — the smallest possible unit of information, the most stable possible oscillation, the purest possible signal.

Hang on-are people actually using this stuff, now, in like, August 2026? Yup: the kit is suddenly appearing in many fields: mapping quantum materials, stabilising next‑generation clocks, imaging nanoscale structures, and even probing biological systems without damaging them. It’s not an incremental upgrade; it’s a shift in what measurement science can do, when the mood takes it. [2] [3]

Why have you showcased it? because it represents science at its most elegant. Quantum sensing isn’t about building bigger machines or consuming more power; it’s about learning to see the world with new eyes. Many of the sensors themselves are tiny jewels of engineering — diamonds with engineered defects, single trapped ions, levitated nanoparticles — each one a reminder that progress sometimes comes from finesse rather than force. In a year dominated by loud technologies, quantum sensing is the quiet triumph: a discipline that turns the universe’s weirdness into clarity, and shows how much beauty there is in simply measuring the world more truthfully.

Can I buy one in my local hardware store? A: Not quite yet. Quantum sensors are still the domain of research labs, national metrology institutes and a few very specialised companies. For now, your local hardware shop will continue to offer the trusty tape measure, the spirit level and the laser rangefinder — all perfectly good tools until quantum sensing makes its way into everyday kit. Think of it as the future arriving in slow, elegant steps rather than on the shelves of B&Q.

However: Most advances in science-and the human condition- ultimately come from advances in measurement. We think this might be one such

[1] Quantum sensor – Wikipedia

[2]Quantum sensors for biomedical applications | Nature Reviews Physics

[3] Quantum Imaging and Sensing – Recent articles and discoveries | Springer Nature Link

#quantum sensor #quantum computer #nanoscale #physics #biology #technology #measurement

Sepsis v antibiotics: the Doctor’s dangerous dilemma

Photo by Tima Miroshnichenko on Pexels.com

Anyone visiting the South Coast towns of England will know we have a huge sepsis awareness campaign on at the moment, as every ambulance you see is plastered with messages on the subject. And rightly so: sepsis is the cause of enormous suffering and mortality, not to mention its toll on NHS resources. Which is why today we are showcasing the NHS sepsis framework (published only yesterday, gentle readers-we sure do scoop ‘em these days!) [1]. because down in the appendix is a little section which impinges directly on the fons et origo of this whole humble blog: microbial resistance to antibiotics, as if you haven’t guessed already. Because sepsis affords the physician the most awful, excruciating, dilemma.

It’s one of those medical emergencies where every hour counts, truly. When bacteria invade the bloodstream and the immune system spirals out of control, doctors just can’t wait days for laboratory cultures. Broad spectrum antibiotics must be thrown in immediately, because delay will be truly deadly. Maybe it’s sepsis, maybe it isn’t: but the only logical decision at that stage is to assume that it is.

Thereby creating an acute paradox. Because prescribing the antibiotics exerts evolutionary pressure on the bacteria, increasing the strain’s likelihood of developing resistance. And as we know here (LSS passim) every unnecessary course of antibiotics puts the bacteria one step ahead. Modern medicine is trying to perform two contradictory tasks: treat, but avoid overtreatment So although the report puts it in the calm precise language of an official report, sepsis management and antimicrobial resistance must be seen as two sides of the same coin.

And our thoughts? Firstly, we are full of admiration for the medical staff who are dropped into this agonising situation, recognising that they possess levels of emotional and intellectual intelligence far beyond our own limited capacities. Secondly that to shout for “more antibiotics“ is cheap rhetoric, as it just begs the question. And we’re always doing it anyway. A more fruitful answer might lie in things like better DNA sequencing, molecular diagnostics and AI assisted decisions, all of which might better identify the invading pathogen more quickly. Thus opening the possibility of a bespoke antibiotic to be delivered to the right patient at the right time. Now that would be a creative step indeed.

[1] NHS England » Sepsis modern service framework

#antibiotic resistance #medicine #health #microbiology #bacteria #sepsis #treatment

Only evidence will do: book review from Nature Briefing

What happens when Belief triumphs over evidence? Here’s one example. For most of human history, childbirth was dangerous in a way modern readers struggle to imagine. In Europe in the early 19th century, maternal mortality in hospitals could reach 10–20% in bad years. Women died not from the birth itself but from the mysterious, terrifying scourge of puerperal fever. And the explanations? The usual cocky self-serving assertions like miasmas, divine wrath, atmospheric changes. Most Doctors were confident; they knew. When thinkers like Semmelweiss suggested that the cause was filthy medical practices which spread a lethal agent he called “germs,” he was hounded from his profession. The carnage continued until Pasteur and others were finally able to show the true causes, which they did using controlled experiments, rigorous data ,and logical interpretation of their findings.

Those who think such battles to be long won would do well to read the following book review from Nature Briefings. It’s called How we know: the rise of evidence based medicine, But it’s really a gateway to how we know about anything, as opposed to just believing our own first guess

In Beyond Belief, science journalist and Nature editor Helen Pearson charts the rise of evidence-based medicine and explores how rigorous research has transformed health and social policy. Pearson shares examples of success stories, in which solid evidence overturned bad practices, and the people behind them, many of whom were treated as mavericks for championing randomized trials. “Anyone can read and enjoy the book, yet there are nuggets for experienced readers,” writes public-policy researcher Peter John in his review. “The author writes as a believer, and her passion is engaging.”

Nature | 8 min read

At this blog we have tried many times that only reason and evidence will ultimately ameliorate the human condition. But nowhere have we done as well as this book does. And the need is not just in medicine, but in all areas such as climate physics, economics and what still passes for political life. The central problem m is that humans are wired for belief, not evidence. Intuition, anecdote, tradition, and authority shape most human decision‑making. Cognitive biases — confirmation bias, availability bias, motivated reasoning establish certainty long before any data has arrived. Yet the cost of ignoring evidence is enormous: this summer wildfires are again raging across Europe in a way unknown before 2020. Pearson’s remedy is the same old list our side has been pushing since the age of Sir Francis Bacon : demand clear causal claims, ask what the comparison group was, look for replication,, distrust single studies, favour interventions tested in real‑world conditions, accept that “what works” is often context‑dependent But try explaining all that in the bar of the Dog and Duck.

Beyond Belief: How Evidence Shows What Really Works by Helen Pearson (Princeton, 2026)

BBC – History – Francis Bacon

#medicine #science #evidence #reason #experiments #rationality #disease #climate change #politics

We learn something new about cancer from a great website called The Scientist

One thing we value here is a well‑written science story that tells us something we didn’t know — and does so in a trustworthy, responsible way. Not the sensationalist, attention‑grabbing material that flashes across our screens all too often. So when our researchers came across Colorectal Cancer and Childhood Exposure to a Common Gut Bacterium by Laura Tran in The Scientist[1], we decided to look at the source itself, to see whether it deserves a place among the canon of science‑news providers we consider worthy of your attention, gentle readers.

As you might expect, The Scientist specialises in clear, sober reporting: across the biosciences, speaking very broadly. The style is terse and informative, closely aligned in spirit with the journals and institutions it covers. There’s a strong news section, a quarterly print magazine, topic‑based browsing, and a generous set of resources. Our test search — naturally, Antibiotics — produced several well‑illustrated, highly informative pieces.

If pressed, we’d say the ideal reader is intelligent, graduate or postgraduate, and probably working somewhere in the life sciences. But there is plenty here for teachers preparing a good science lesson too. Or even two.

Our verdict: not as bite‑sized as Nature Briefing, nor as magazine‑like as New Scientist, The Scientist nevertheless earns a worthy place alongside them as a provider of news and ideas for the educated and reasonable community (that’s us, gentle readers). And in an age when so much content is shaped for attention rather than understanding, that’s a very important thing indeed.

And having satisfied ourselves that The Scientist is indeed a sober and reliable chronicler of the biosciences, we can turn to the story that brought us there in the first place. It is a quietly important one: evidence that early‑life exposure to certain strains of that perfectly ordinary gut bacterium — Escherichia coli carrying a particular genetic island — may leave a mutational fingerprint that shows up years later in colorectal tumours. No melodrama, no scare‑stories, just the steady accumulation of data: mutational signatures, epidemiology, and the slow, careful work of linking mechanism to disease. This is exactly the sort of thing the scientific enterprise does well, and exactly the sort of thing we like to bring to your attention.

[1] https://www.the-scientist.com/childhood-exposure-to-bacterial-toxin-tied-to-early-onset-colorectal-cancer-72952?fbclid=IwY2xjawSxsvNleHRuA2FlbQIxMABicmlkETBVNUo0ekNo

#cancer #medicine #science #life science #research #laboratory #start up #biotechnology

CRISPR meets Epigenetics: a marriage made in Heaven

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a natural defence system found in bacteria, which scientists have turned into a programmable way to edit genes with extraordinary precision. In practice, it comprises two parts: a guide RNA that acts like a GPS to find the exact spot in DNA, and a Cas9 enzyme that acts like molecular scissors to cut the DNA. Once the DNA is cut, scientists can delete, fix, or replace genetic sequences inside a living cell. Our first Cover seems to have been over six years ago (LSS 23 11 20), since when we have noted a startling range practical applications from areas as diverse as horse breeding, and sickle cell medicine, to its relationship with blue sky techniques such as Base Pair editing, CART and programmable therapeutics (LSS passim).

How gratifying then to see CRISPR-based tools now partnered with epigenetics, that other old favourite of these humble pages! Once again the lead is taken by the indispensable Nature Briefing, now our go-to for all new things Scientific Their summary CRISPR’s next act: editing the epigenome tells you most of what you need to know. But some readers may well wish to click on the handy link too

A handful of start-up firms are testing therapies that target specific epigenetic markers — essentially chemical groups that sit on DNA and the proteins that it is wound around — to treat everything from high cholesterol to a rare muscular disorder. Changing these chemical markers can switch genes on or off. Some existing medications influence epigenetic markers, but these drugs act broadly and lack specificity. A new cadre of scientists has found ways to precisely alter the epigenetic signals that influence specific genes.

Nature | 15 min read

There is much here to gladden the hearts of all who believe in Reason and Learning. The technique seemingly so radical a few short years ago is not only becoming routine, it is embedding itself into the wider corpus of medical and scientific practice. Practicable applications are multiplying and the opportunities to reduce human and animal suffering are thereby multiplying. If anyone asks us “why do you take such an interest in the progress of the Arts, Sciences and Letters?” one answer we give is: because of things like this.

If you want to know more about epigenetics, or molecular biology in general, then we cannot do better than recommend the works of the great Professor Carey:

Carey, Nessa. The Epigenetics Revolution: How Modern Biology Is Rewriting Our Understanding of Genetics, Disease, and Inheritance.London: Icon Books, 2011. New York: Columbia University Press, 2012. ISBN: 9781848312920 (Icon Books); 9780231530712 (Columbia UP).

Carey, Nessa. Hacking the Code of Life: How Gene Editing Will Rewrite Our Futures.London: Icon Books, 2019. New York: Columbia University Press, 2019. ISBN: 9781785784972 (Icon Books); 9780231549769 (Columbia UP).

#molecular biology #genetics #epigenetics #CRISPR Cas 9 #medicine #health #DNA #RNA

Gene Megacluster: a really big moment in antibiotic research

The idea of whole and unexpected possibilities in antibiotic research excites our highest hopes-and those of readers who have accompanied us on this journey for years. None more so than this report from Nature Briefing Gene Megacluster boosts antibiotic arsenal. We’ve set up their usual summary, plus links: and then we’ll try to answer a few of your questions as best we are able

A newly discovered gene ‘megacluster’ in Streptomyces bacteria enables them to produce a variety of potent antibiotic compounds. These compounds act as a multi-pronged offensive weapon against other species, with each targeting different stages of the bacterial metabolic process. It’s more difficult for bacteria to develop resistance to attacks that hit several targets, so the discovery could lead to the development of new antibiotics, experts say. The research has “discovered something new in a system so extensively studied — hidden in plain sight,” says medicinal chemist Mark Blaskovich

Nature | 4 min read
Reference: Nature paper

So, what is this gene megacluster? An unusual stretch of DNA in Streptomyces that encodes four distinct families of natural-product antibiotics, including: one compound entirely new to science, another never previously recognised as an antibiotic, and two known families deployed in a new coordinated fashion. Not a bad haul for one discovery, we think.

What does it do in Streptomyces? All four molecules target biotin (vitamin B7)—a universal cofactor required for growth, cell division, and metabolic enzyme function in most bacteria. They attack different points in the biotin pathway: production, uptake, use, and availability, aided by flanking streptavidin genes that bind up free biotin.

Why is this discovery genuinely new? Well , all sorts of reasons: here are a few of the best

–Co-location is unheard of: Antibiotic biosynthetic pathways are usually scattered across the genome. Here, four unrelated antibiotic families sit side-by-side, implying intentional evolutionary selection.

–Coordinated multi-antibiotic strategy: Natural antibiotics typically act alone. This cluster encodes a team of molecules that hit the same vulnerability from different angles—something not previously documented.

–Hidden in plain sight :Streptomyces genomes have been mined for decades, yet this megacluster was overlooked because genome-mining tools historically focused on single-product clusters. We love this bit, as regular readers will have already discerned

–It appears to be widespread. The megacluster is present across multiple Streptomyces species, suggesting an ancient, conserved strategy rather than a rare curiosity.

Could similar clusters exist in other organisms? Likely, yes. The discovery provides a road map for genome mining that looks for coordinated multi-pathway clusters, not just single biosynthetic islands Early research might do better to focus on procaryotes rather than eucaryotes-but who knows?

How could it help us to develop new antibiotics? This is the Big One for us , isn’t it? Lots of ways potentially, but as of late June 2026 three practical routes suggest themselves:

1. Direct development of the four biotin-targeting molecules. Because they attack different steps in the same essential pathway, they could be: used individually, combined as a cocktail, or engineered into hybrid molecules. Multi-target antibiotics are inherently harder for pathogens to resist. So that will teach them we’re serious this time.

2. Synthetic biology reconstruction. The megacluster’s architecture can be transplanted into: Streptomyces strains, E. coli or yeast expression systems, or modular cell-free platforms, permitting all sorts of scaling and production advantages

3. Drug discovery by analogy The discovery provides a template: look for clusters that coordinate attacks on other essential pathways (e.g., folate, isoprenoid synthesis, lipid II). Genome mining guided by this logic could uncover dozens of new multi-pronged antibiotic families.

4. Biotin-pathway inhibitors as a new class Biotin metabolism is conserved across many pathogens, including Gram-negatives—historically hard to target. These molecules could seed a new class of antibiotics that bypass existing resistance mechanisms

At this blog we tend to rate discoveries by the possibilities they open rather than the questions they answer. By that metric, this one is big indeed-and we think you’ll al agree with that.

#antibiotic research #antibiotic resistance #health #medicine #biotechnology #genetic engineering #research #bacteria

Round up for this week: What’s the biggest living thing. how many quantums in an atom, lupus progress-and international relations

Fungal internet Its not whales or trees:Some of the largest living things on our planet are actually vast networks of microscope white fungi growing beneath the ground on which we unthinkingly tread as The Conversation explains;

https://theconversation.com/fungal-highways-are-vast-yet-hidden-underground-new-study-285166?utm_medium=email&utm_campaign=Latest%20from%20The%20Conversa

Don’t expect Putin to go quietly if he loses in Ukraine If you think current developments in the Russian Ukraine war might lead to a status quo ante bellum, think again ,as this prescient article from the Guardian makes clear

https://www.theguardian.com/commentisfree/2026/jun/14/vladimir-putin-ukraine-war-borders-russian-president

Plant a tree in ‘73, plant some more in ‘74 was a Government slogan from our long distant youth But maybe trees won’t save us from climate change as well as we thought they might as this piece from The Guardian explains

Trees may store less planet-heating carbon than hoped, study suggests | Greenhouse gas emissions | The Guardian

A bestiary of bosons Nothing so defeats us as the vast and baffling variety of particles ,waves and other strange things that make up the modern atom .So we welcomed this article from Nature Briefing which tries to make sense of the matter

How many elementary particles are there?

Even if you know your fermions from your bosons, the actual number of fundamental particles — the electrons, quarks and other building blocks of physics — is still uncertain. From the 17 that feature on posters on classroom walls, “where you stop depends on your taste for complexity and mystery”, explains science writer Natalie Wolchover. “Plausible answers range from 17 to — in all seriousness — 995.5.”

Quanta | 13 min read

Lupus in remission Just before we pressed the “SEND” button, our researchers insisted that this encouraging story about a new immunological technique which seems to be turning the tide on the debilitating disease of Lupus went in, Good for them. here’s the BBC

‘I’ve never been this good’ – revolutionary immune reset puts lupus in remission – BBC News

Quote of the week

He that hasteth with his feet sinneth.” (Proverbs 19:2)

#lupus #immunology #fungi #Russia #physics #quantum physics #vladimir putin #trees